DMF-loaded SLN administrated by inhalation route attenuate clinical signs and reduce lung and CNS inflammation in MS animals' model

Pinto, Bárbara Fernandes; Silva, Gisela Bevilacqua Rolfsen Ferreira da; Kraemer, Lucas; Santos, Gabryella Soares Pinheiro dos; Bèla, Samantha Ribeiro; Leite, Fábio de Lima; Oliveira, Anselmo Gomes de; Birbrair, Alexander; Russo, Remo Castro; Tavares, Juliana Carvalho Tavares.
No convencional en Inglés | ARCA | ID: arc-46612

Documentos relacionados

  1. The Ins and Outs of Central Nervous System Inflammation-Lessons Learned from Multiple Sclerosis.
  2. Bone marrow hematopoiesis drives multiple sclerosis progression.
  3. Targeting PGLYRP1 promotes antitumor immunity while inhibiting autoimmune neuroinflammation.
  4. Animal models of multiple sclerosis: From rodents to zebrafish.
  5. Acute intermittent hypoxia alters disease course and promotes CNS repair including resolution of inflammation and remyelination in the experimental autoimmune encephalomyelitis model of MS.
  6. B cell-dependent EAE induces visual deficits in the mouse with similarities to human autoimmune demyelinating diseases.
  7. NFAT5 contributes to the pathogenesis of experimental autoimmune encephalomyelitis (EAE) and decrease of T regulatory cells in female mice.
  8. CSF1R antagonism results in increased supraspinal infiltration in EAE.
  9. Age-related changes in multiple sclerosis and experimental autoimmune encephalomyelitis.
  10. Regulation of neuroinflammation by B cells and plasma cells.